AddLife signs agreement with Wellspect HealthCare

Expansion on 13 new markets

AddLife acquires Austrian Biomedica

Invest in AddLife

All published financial information and tools to facilitate investment decisions.

Long-term sustainable development

Sustainability operations are a natural part of our business value.

Expansion in 13 new markets in Eastern Europe

AddLife acquires Austrian Biomedica, a parent company in a group with a turnover of approximately EUR 65 million, operating in 13 countries in Europe with 280 employees. Biomedica supplies, like AddLife, products and services in laboratory engineering and medical technology to mainly publicly funded healthcare. Biomedics becomes part of both Medtech and Labtech.

Annual Report 2017

DOWNLOAD

LABTECH

Labtech offers products and services to diagnostics and biomedical research and laboratory analysis.

MORE ABOUT LABTECH

MEDTECH

Medtech offers medical device products to the publicly funded health care.

MORE ABOUT MEDTECH

AQUISITIONS

We develop your company through active ownership. AddLife acquires companies in order to maintain and further develop them in the long term.

MORE ABOUT AQUISITIONS

Life Science in the Nordics

The Nordic countries, AddLife’s home market, have a growing and aging population, which increases the need for health care and social services. Constructive collaboration between  society, research and business is therefore important to meet the expectations of citizens. AddLife actively contributes with its high-quality laboratory and medical technology.

SOCIAL RESPONSIBILITY

Our vision is to improve people's lives, for example by sponsoring: